- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 453/02 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Patent holdings for IPC class C07D 453/02
Total number of patents in this class: 671
10-year publication summary
|
62
|
69
|
41
|
60
|
49
|
50
|
31
|
27
|
35
|
4
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chiesi Farmaceutici S.p.A. | 940 |
41 |
| Bristol-myers Squibb Company | 5080 |
16 |
| Astellas Pharma Inc. | 1145 |
16 |
| Glaxo Group Limited | 4496 |
15 |
| Genzyme Corporation | 1205 |
15 |
| Novartis AG | 11238 |
14 |
| Corsair Pharma, Inc. | 35 |
13 |
| Renexxion, LLC | 16 |
13 |
| Merck Patent GmbH | 5909 |
11 |
| Hovione Scientia Limited | 136 |
10 |
| AstraZeneca AB | 3042 |
9 |
| Vertex Pharmaceuticals Incorporated | 1581 |
9 |
| Array BioPharma Inc. | 551 |
8 |
| Attenua, Inc. | 14 |
8 |
| Obschestvo S Ogranichennoi Otvetstvennostiyu "pharmenterprises" | 34 |
8 |
| SK Biopharmaceuticals Co., Ltd. | 248 |
8 |
| Beijing Showby Pharmaceutical Co., Ltd. | 14 |
8 |
| Boehringer Ingelheim International GmbH | 4629 |
7 |
| Almirall, S.A. | 534 |
7 |
| Mitsubishi Tanabe Pharma Corporation | 579 |
7 |
| Other owners | 428 |